期刊文献+

13例不完全川崎病的临床分析 被引量:1

Clinical Anlysis of Incomplete Kasawaki Disease:13 Cases
下载PDF
导出
摘要 目的分析不完全川崎病的临床资料,观察其临床特征,为临床诊断治疗提供指导。方法诊断参照第三届国际KD会议修订的诊断标准和美国心脏协会推荐的不完全川崎病诊断指南,结合临床经验,分析总结13例不完全川崎病患儿各种临床表现及其出现时间和几率。结果小于1岁者发病者5例,1~5岁者4例,大于5岁发病4例,平均年龄3.5岁,年龄最小3个月,年龄最大9岁。发热、皮疹、淋巴结肿大、指(趾)末端脱皮、双球结膜充血、唇红皲裂的发生率分别为100%、38.4%、38.4%、38.4%、46.1%、53.8%。指(趾)末端脱皮、肛周皮肤、阴囊皮肤潮红在起病在病程的第1~2周,病程2周内发生心脏冠状动脉病变达60%。本病主要用口服阿司匹林和大剂量静脉注射丙种球蛋白治疗。结论发热、淋巴结肿大、皮疹、唇和口腔黏膜改变是川崎病的早期主要临床表现。肛周潮红及其脱皮、阴囊脱皮、血小板(PLT)增高、肝酶、C反应蛋白(CRP)和血沉(ESR)升高有早期诊断的价值。不完全川崎病疑似病例应尽早行超声心动图检查,心脏冠脉病变可以为诊断提供有力证据,且尽早正规治疗可明显提高预后。 Objective Retrospectively study clinical datas of 13 children with incomplete Kawasaki disease (KD), observe and an- lyze their clinical characteristics. Methods The diagenosis of incomplete KD was based on the criteria refined on the third international KD conference and the supplemental laboratory criteria and endocardiographic crteria prepared by Amecican Heart Assocication (AHA). meanwhile, pediatricians ~xperiences played a important role in the diagnosis of incomplete KD. anlyze their varified and atyp- ical performances as well their onset time and probablities of occurence. Results Average age of onset was three and a half years old, with extremities of three months and 9 years. Occurence rate of fever,polymorphous truncal rash,lymphadenopathy,changes of periph- era; extremities,conjuncfivM congestion,changes of lips and oral cavity was 100% ,38.4% ,38.4% ,38.4% ,46.1% ,53.8% respec- tively, desquamation of skin from the figertips ,blush of perianal and scrotum skins occured in the first to sencond week of the disease course, as hagh as 60% coronal abnomabilities took place in the first two weeks. Orally administration of aspirin and intravenous drip of immLme globin were the main treatments. Conclusion Fever, lymph node elargement, rash, changes of lips and oral cavity are the main- ly ealy manifestition, blush and desquamation around the perineum, elevation of PLT, AST, CRP and ESR has great value for early daignosis, once suspicion of incomplete KD founded, a ultrasonic cardiogram should be implemented immediately, coronary abnomality can be used as a vowerful evidence for KD.
作者 吕银 吕文丽
出处 《哈尔滨医药》 2013年第2期103-104,共2页 Harbin Medical Journal
关键词 不完全川崎病 诊断 临床特征 Incomplete kawasaki disease Diagonosis Clinical features
  • 相关文献

参考文献4

  • 1Sonobe T,Kiyosawa N ,Tsuchiya K,et al. Prevaleneeof coronary ar- tery abnormality in incomplete Kawasaki disease[ J]. Pediatr lnt, 2007,49:421 - 426.
  • 2Manlhiot C,Chr/stie E,McCrindle BW,et al. Complete and incom- plete Kawasaki disease:two sides of the same coin[ J]. Eur J Pedi- air,2012,171(4) :657 -662.
  • 3ROWLEY A H,SHULMAN S T. Kawasaki disease[ M].//BEHR- MAN R E, KL IEGMA RM, AR IVIN AM J. Nelson Textbook of Ped ia trics. 16thed. Ph iladellphia: W. B. Saunders, 2000:725 - 727.
  • 4于宪一.川崎病治疗的现状和展望[J].实用儿科临床杂志,2004,19(11):922-924. 被引量:42

二级参考文献15

  • 1Saulsbury FT. Comparison of high - dose and low - dose aspirin plus intravenous immunoglobulin in the treatment of kawasaki syndrome [J]. Clin Pediatr (Phila) ,2002,41 (8):597 - 601.
  • 2Khowsathit P, Hong- Hgam C, Khositseth A, et al. Treatment of Kawasaki disease with a moderate dose (1g/kg) of intravenous immunoglobulin[J]. J Med Assoc Thai, 2002, 85 (suppl): S1121-S1126.
  • 3Terai M, Shulman ST. Prevalence of coronary artery abnormalities in kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose [J]. J Pediatr, 1997, 131 (6): 888 -893.
  • 4Nishikawa M, Ichiyama T, Hasegawa M, et al. Safety from thromboembolism using intravenous immunoglobulin therapy in kawasaki disease: study of whole - blood viscosity[J]. Pediatr Int, 2003,45(2): 156- 158.
  • 5French JW, Kahn SJ. Initial intravenous gammaglobulin treatment failure in kawasaki disease[J]. Pediatrics,2000,105(6) :78.
  • 6Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin- resistant Kawasaki disease with pulsed doses of corticosteroids[J]. J Pediatr, 1996,128(1): 146 - 149.
  • 7Sundel RP, Baker AL, Fulton DR, et al. Corticosteroids in the initial treatment of kawasaki disease: report of a randomized trial[J]. JPediatr, 2003,142 (6): 611 - 666.
  • 8Lee MS, An SY, Jang GC, et al. A case of intravenous immunoglobulin resistant kawasaki disease treated with methotrexate [J ]. Yonsei Med J,2002,43 (4): 527 - 532.
  • 9Hitoshi H, Toshio S, Tomoyuki M. Successful thrombolysis with intracorronary administration of tissue plasminogen activator in an infant with kawasaki disease[J]. Heart, 1997,78: 517 - 518.
  • 10菌部友良 土屋惠司 片冈正.川崎病[J].小儿科临床,1994,47:689-694.

共引文献41

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部